Skip to Content for Eligibility and Application Menu for Eligibility and Application About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

Eligibility and Application

Eligibility and Application Process For 2009-2010, the Genentech ITGR group will select three to five qualified Clinical Research Fellows through a competitive application process. Each selected Fellow will be based in Genentech's South San Francisco headquarters office.

Eligibility Criteria

  • The Fellowship is open to third- and fourth-year Fellows in major academic institutions in the United States.
  • Exceptional senior residents might also be considered as Fellowship candidates.
  • Fellows and their academic institutions must agree to uphold Genentech confidentiality and intellectual property contracts.
  • Fellows must be able to work in Genentech’s South San Francisco headquarters.

Application Process

  • Fellowship applications will be accepted through March 31, 2009, for the 2009-2010 program/academic year. Incomplete applications will not be considered. Applications received after the deadline will be held for consideration for the following year’s program.
  • The program will start in July 2009 on a date mutually determined by Genentech and the selected Fellows.
  • All non-selected applicants are eligible to re-apply in subsequent years in accordance with eligibility criteria.  
  • To apply, please email us and include your name, address, contact information, curriculum vitae and cover letter. Your cover letter must specify the therapy of interest, the rationale for selecting this therapy and initial ideas about the Fellowship research initiative.

Apply for an Immunology Clinical Research Fellowship To apply, email us the following:

  • Name
  • Address
  • Contact Information
  • Curriculum vitae
  • Cover Letter

Your cover letter must specify the therapy of interest, the rationale for selecting this therapy and initial ideas about the Fellowship research initiative.